A metastatic breast cancer drug, discovered in the McDonnell Lab, is now FDA-approved—the first new oral endocrine therapy in 20+ years. Another might not be so far behind.
John Strickler, MD, and team's milestone work on the clinical trial "MOUNTAINEER" has led to the first FDA-approved treatment regimen for HER2+ metastatic colorectal cancer.
The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.
You can count on one hand the number of times a young graduate student finds a drug, then the drug is patented, licensed, and in a phase 2 trial within a couple years.
Carey Anders, MD, and immunology researchers Erika Crosby, PhD, Zachary Hartman, PhD, among featured speakers at the national Komen MBC webinar series.
Katrina Cooke has beaten the odds; surviving nearly nine years with metastatic breast cancer. Giving of her time to make things better for others has been her lifeline.
Komen NCTC hosts its first annual gala to support metastatic breast cancer research; a virtual event with speakers, auctions, and treats on Saturday, October 10, at 7 p.m.
A new approach to training computational models on biological processes provides insights into how and why cancer cells metastasize to certain areas of the vasculature.
Dorothy Sipkins, MD, PhD, and P. Kelly Marcom, MD, are co-PIs on a Phase 1 clinical trial of a new drug for breast cancer patients whose disease has spread to the bone.
Researchers at MIT and Duke have discovered that a compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.
In partnership with the Duke School of Medicine, Duke Cancer Institute, Duke Department of Surgery, and the IBC Network Foundation, the Duke Consortiu...
A jagged little protein appears to be a key to how cancer stem cells differentiate and enable metastasis, according to researchers at the Duke Cancer ...
Join us at facebook.com/dukecancerinstitute on Wednesday, May 1, at noon for a live panel discussion featuring cancer survivor and cycling enthusiast ...